Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
John Nicholson currently holds 162,759 shares of NEKTAR THERAPEUTICS (NKTR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John Nicholson has been a net seller of NKTR stock. They have purchased $0 and sold $32.2M worth of shares.
John Nicholson's most recent insider trade was on Aug 16, 2019, when they sold 3,819 shares at $18.15 per share.
John Nicholson serves as Executive at NEKTAR THERAPEUTICS (NKTR). They have executed 44 insider transactions totaling $32.2M over their tenure at the company.
John Nicholson holds the position of Executive at NEKTAR THERAPEUTICS, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 17 years and currently hold a stake valued at $0.
John Nicholson has shown a selling trading pattern, with $0 in total purchases and $32.2M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by John Nicholson was on Mar 6, 2018, when they sold $11.8M worth of NKTR shares. This transaction involved 120,000 shares at $98.29 per share.
John Nicholson currently owns 162,759 shares of NEKTAR THERAPEUTICS (NKTR), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of John Nicholson's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. John Nicholson has 44 Form 4 filings on record as an insider at NEKTAR THERAPEUTICS.
Set alerts for John Nicholson and 40,000+ other insiders.